NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 263 filers reported holding NOVOCURE LTD in Q2 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $213,016 | -2.3% | 3,542 | +34.7% | 0.01% | -40.0% |
| Q1 2022 | $218,000 | +0.9% | 2,630 | -8.5% | 0.02% | -11.8% |
| Q4 2021 | $216,000 | -29.4% | 2,873 | +9.2% | 0.02% | -45.2% |
| Q3 2021 | $306,000 | -63.7% | 2,632 | -30.8% | 0.03% | -69.6% |
| Q2 2021 | $844,000 | +301.9% | 3,805 | +139.3% | 0.10% | +175.7% |
| Q1 2021 | $210,000 | – | 1,590 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |